Burt A. Adelman, Director at Verve Therapeutics, Inc. (VERV), bought 4,700 shares at $31.34 ($147K) on 2021-12-02, disclosed to the SEC on 2021-12-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| DYAX | SELL | 2015-03-06 | $147K | — | Filing → |
| DYAX | SELL | 2015-01-05 | $1.1M | — | Filing → |
| DYAX | SELL | 2014-03-03 | $532K | — | Filing → |